BIOMAT Database Logo BIOMAT Database Logo

Lack of inhibition by L-tryptophan or quinolinate of gluconeogenesis in diabetic rats. 1974

F L Alvares, and P D Ray

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010728 Phosphoenolpyruvate A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.
D010729 Phosphoenolpyruvate Carboxykinase (GTP) An enzyme of the lyase class that catalyzes the conversion of GTP and oxaloacetate to GDP, phosphoenolpyruvate, and carbon dioxide. This reaction is part of gluconeogenesis in the liver. The enzyme occurs in both the mitochondria and cytosol of mammalian liver. (From Dorland, 27th ed) EC 4.1.1.32. GTP-Dependent Phosphoenolpyruvate Carboxykinase,Carboxykinase, GTP-Dependent Phosphoenolpyruvate,GTP Dependent Phosphoenolpyruvate Carboxykinase,Phosphoenolpyruvate Carboxykinase, GTP-Dependent
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete

Related Publications

F L Alvares, and P D Ray
[Inhibition mechanism of gluconeogenesis by tryptophan].
December 1969, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
F L Alvares, and P D Ray
Inhibition of hepatic gluconeogenesis by tryptophan metabolites in rats and guinea pigs.
July 1979, Biochemical pharmacology,
F L Alvares, and P D Ray
Inhibition of renal gluconeogenesis by guinolinate and hydrazine in diabetic rats.
October 1975, Endocrinology,
F L Alvares, and P D Ray
Inhibition of gluconeogenesis by tryptophan and its metabolites.
January 1978, Biochemical Society transactions,
F L Alvares, and P D Ray
Inhibition of gluconeogenesis in rat renal cortex slices by metabolites of L-tryptophan in vitro.
January 1975, Naunyn-Schmiedeberg's archives of pharmacology,
F L Alvares, and P D Ray
Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
February 2011, PloS one,
F L Alvares, and P D Ray
Paths of carbon in gluconeogenesis and lipogenesis. IV. Inhibition by L-tryptophan of hepatic gluconeogenesis at the level of phosphoenolpyruvate formation.
September 1966, The Journal of biological chemistry,
F L Alvares, and P D Ray
Inhibition of gluconeogenesis by hydrazine administration in rats.
May 1967, The Journal of pharmacology and experimental therapeutics,
F L Alvares, and P D Ray
Inhibition of renal gluconeogenesis in rats by ochratoxin.
June 1979, The Biochemical journal,
F L Alvares, and P D Ray
Quinolinate inhibition of gluconeogenesis is dependent on cytosolic oxalacetate concentration. An explanation for the differential inhibition of lactate and pyruvate gluconeogenesis.
September 1985, FEBS letters,
Copied contents to your clipboard!